DRUG logo

Bright Minds Biosciences Inc. (DRUG)

Profile

Full Name

Bright Minds Biosciences Inc.

Ticker

NASDAQ: DRUG

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 22, 2021

Indexes

Not included

Website

https://brightmindsbio.com

Employees

-

Key Details

Price

$33.63(-0.41%)

Market cap

$238.21M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.48(+67.44% YoY)

PE ratio

-

Next earnings date

Aug 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $33.63
    DRUG price is $33.63

    30-Day Relative Volume

    0.74
    DRUG 30-day relative volume is 0.74

    Price Performance

    Price Most recent change

    -0.41%
    DRUG price was down -0.41% on Aug 1, 2025

    Price YTD change

    -6.64%
    DRUG price is down -6.64% since January 1st

    Price 1-year change

    +2799.14%
    DRUG price is up +2799.14% year-on-year

    Price 3-year change

    +668.69%
    DRUG price is up +668.69% over the past 3 years

    Price Range

    Price All-time high

    $79.02
    DRUG price is currently -57.44% below its historical high of $79.02

    Price 3-year low

    $0.93
    DRUG price is currently +3516.13% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $238.21M
    DRUG market capitalization is $238.21 million

    Market cap 3-year change

    +2193.11%
    DRUG market capitalization is up +2193.11% over the past 3 years

    Market cap All-time high

    $388.97M
    DRUG market capitalization is currently -38.76% below its historical high of $388.97 million

    Market cap sector rank

    55.08%
    DRUG market capitalization is higher than 55.08% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +58.68%
    DRUG shares outstanding is up +58.68% year-on-year

    Shares Outstanding 3-Year Change

    +198.32%
    DRUG shares outstanding is up +198.32% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -1.81
    DRUG beta is -1.81

    200-day SMA

    $34.79
    DRUG price is currently -3.34% below its 200-day simple moving average

    50-day SMA

    $28.08
    DRUG price is currently +19.75% above its 50-day simple moving average

    RSI

    64.39
    DRUG 14-day relative strength index is 64.39

    Volume

    0.74
    DRUG 30-day relative volume is 0.74

    ATR

    $2.59
    DRUG average true range is $2.59

    10-day Historical Volatility

    92.55%
    DRUG 10-day historical volatility is 92.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    DRUG annual revenue value is unknown

    Revenue Analysts estimate

    -
    DRUG annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    DRUG annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    DRUG annual revenue is unknown

    EPS

    EPS

    -$0.48
    DRUG annual earnings per share is -$0.48

    EPS Analysts estimate

    -$2.53
    DRUG annual earnings per share is currently -81.12% lower than the consensus analysts' forecast

    EPS 1-year change

    +67.44%
    DRUG annual earnings per share is up +67.44% year-on-year

    EPS Sector rank

    68%
    DRUG annual earnings per share is higher than 68% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DRUG annual gross profit value is unknown

    Gross margin

    -
    DRUG annual gross profit margin value is unknown

    Operating profit

    -$2.07M
    DRUG annual operating income is -$2.07 million

    Operating margin

    -
    DRUG annual operating profit margin value is unknown

    Net income

    -$2.06M
    DRUG annual net profit is -$2.06 million

    Net margin

    -
    DRUG annual net profit margin value is unknown

    Expenses

    Total expenses

    $2.07M
    DRUG annual total expenses is $2.07 million

    Operating expenses

    $2.07M
    DRUG annual total operating expenses is $2.07 million

    Cost of goods sold

    -
    DRUG annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.06M
    DRUG annual SGA is $1.06 million

    Depreciation and amortization

    $53.90K
    DRUG annual depreciation & amortization is $53.90 thousand

    Interest expense

    -
    DRUG annual interest expense value is unknown

    Income tax

    -
    DRUG annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$2.07M
    DRUG annual earnings before interest & taxes is -$2.07 million

    EBITDA

    -$2.02M
    DRUG annual EBITDA is -$2.02 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.52M
    DRUG annual total assets is $4.52 million

    Non current assets

    $87.10K
    DRUG annual long term assets is $87.10 thousand

    Current assets

    $4.43M
    DRUG annual total current assets is $4.43 million

    Cash and cash equivalents

    $4.23M
    DRUG annual cash & cash equivalents is $4.23 million

    Accounts receivable

    -
    DRUG annual accounts receivable value is unknown

    Inventory

    -
    DRUG annual inventory value is unknown

    Liabilities

    Total liabilities

    $420.60K
    DRUG annual total liabilities is $420.60 thousand

    Long term liabilities

    $29.30K
    DRUG annual total long term liabilities is $29.30 thousand

    Current liabilities

    $391.30K
    DRUG annual total current liabilities is $391.30 thousand

    Accounts payable

    $301.60K
    DRUG annual accounts payable is $301.60 thousand

    Debt

    Total debt

    $88.10K
    DRUG annual total debt is $88.10 thousand

    Total debt 1-year change

    +62.85%
    DRUG annual total debt is up +62.85% year-on-year

    Long term debt

    $29.30K
    DRUG annual long term debt is $29.30 thousand

    Short term debt

    $58.80K
    DRUG annual short term debt is $58.80 thousand

    Equity & Capital

    Shareholders equity

    $4.10M
    DRUG annual stockholders equity is $4.10 million

    Book value

    $4.10M
    DRUG annual book value is $4.10 million

    Retained earnings

    -$25.42M
    DRUG annual retained earnings is -$25.42 million

    Working capital

    $4.04M
    DRUG annual working capital is $4.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$1.36M
    DRUG annual cash flow from operations is -$1.36 million

    Cash from operations 1-year change

    +73.88%
    DRUG annual cash flow from operations is up +73.88% year-on-year

    Cash from investing

    -
    DRUG annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    DRUG annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $595.70K
    DRUG annual cash flow from financing activities is $595.70 thousand

    Cash from financing 1-year change

    -63.29%
    DRUG annual cash flow from financing activities is down -63.29% year-on-year

    CAPEX

    CAPEX

    -
    DRUG annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    DRUG annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$1.36M
    DRUG annual free cash flow is -$1.36 million

    Free cash flow 1-year change

    +73.88%
    DRUG annual free cash flow is up +73.88% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DRUG annual gross profit margin value is unknown

    Operating margin

    -
    DRUG annual operating profit margin value is unknown

    Net margin

    -
    DRUG annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.57%
    DRUG annual return on assets is -45.57%

    ROE

    -50.25%
    DRUG annual return on equity is -50.25%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DRUG price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DRUG price to earnings ratio is unknown

    PB Ratio

    PB ratio

    6.12
    DRUG price to book ratio is 6.12

    PB ratio Sector rank

    82.9%
    DRUG price to book ratio is higher than 82.9% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DRUG price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DRUG price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $199.42M
    DRUG enterprise value is $199.42 million

    Enterprise value Sector rank

    54.26%
    DRUG enterprise value is higher than 54.26% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -51.95
    DRUG EV/EBITDA is -51.95

    EV/EBITDA Sector rank

    3.36%
    DRUG EV/EBITDA is higher than 3.36% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    11.32
    DRUG annual current ratio is 11.32

    Quick ratio

    -
    DRUG annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.02
    DRUG annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    DRUG annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DRUG piotroski f-score value is unknown

    Altman Z-Score

    -
    DRUG altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 21, 25 Chardan Capital
    Buy
    May 13, 25 TD Cowen
    Buy
    May 7, 25 Chardan Capital
    Buy
    Feb 19, 25 HC Wainwright & Co.
    Buy
    Jan 23, 25 Piper Sandler
    Overweight
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 Cantor Fitzgerald
    Overweight
    Nov 25, 24 Baird
    Outperform

    Institutional Ownership

    Screeners with DRUG included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Bright Minds Biosciences Inc.?
    • Does Bright Minds Biosciences Inc. pay dividends?
    • What sector is Bright Minds Biosciences Inc. in?
    • What industry is Bright Minds Biosciences Inc. in?
    • What country is Bright Minds Biosciences Inc. based in?
    • When did Bright Minds Biosciences Inc. go public?
    • Is Bright Minds Biosciences Inc. in the S&P 500?
    • Is Bright Minds Biosciences Inc. in the NASDAQ 100?
    • Is Bright Minds Biosciences Inc. in the Dow Jones?
    • When was Bright Minds Biosciences Inc.'s last earnings report?
    • When does Bright Minds Biosciences Inc. report earnings?

    What is the ticker symbol for Bright Minds Biosciences Inc.?

    The ticker symbol for Bright Minds Biosciences Inc. is NASDAQ:DRUG

    Does Bright Minds Biosciences Inc. pay dividends?

    No, Bright Minds Biosciences Inc. does not pay dividends

    What sector is Bright Minds Biosciences Inc. in?

    Bright Minds Biosciences Inc. is in the Healthcare sector

    What industry is Bright Minds Biosciences Inc. in?

    Bright Minds Biosciences Inc. is in the Biotechnology industry

    What country is Bright Minds Biosciences Inc. based in?

    Bright Minds Biosciences Inc. is headquartered in United States

    When did Bright Minds Biosciences Inc. go public?

    Bright Minds Biosciences Inc.'s initial public offering (IPO) was on March 22, 2021

    Is Bright Minds Biosciences Inc. in the S&P 500?

    No, Bright Minds Biosciences Inc. is not included in the S&P 500 index

    Is Bright Minds Biosciences Inc. in the NASDAQ 100?

    No, Bright Minds Biosciences Inc. is not included in the NASDAQ 100 index

    Is Bright Minds Biosciences Inc. in the Dow Jones?

    No, Bright Minds Biosciences Inc. is not included in the Dow Jones index

    When was Bright Minds Biosciences Inc.'s last earnings report?

    Bright Minds Biosciences Inc.'s most recent earnings report was on May 15, 2025

    When does Bright Minds Biosciences Inc. report earnings?

    The next expected earnings date for Bright Minds Biosciences Inc. is August 15, 2025
    On this page